142 related articles for article (PubMed ID: 2531863)
1. Antisecretory activity of omeprazole in the conscious gastric fistula cat: comparison with famotidine.
Coruzzi G; Bertaccini G
Pharmacol Res; 1989; 21(5):499-506. PubMed ID: 2531863
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of famotidine on cat gastric secretion.
Coruzzi G; Bertaccini G; Noci MT; Dobrilla G
Agents Actions; 1986 Nov; 19(3-4):188-93. PubMed ID: 2881456
[TBL] [Abstract][Full Text] [Related]
3. Gastric antisecretory activity of lansoprazole in different experimental models: comparison with omeprazole.
Coruzzi G; Adami M; Bertaccini G
Gen Pharmacol; 1995 Sep; 26(5):1027-32. PubMed ID: 7557245
[TBL] [Abstract][Full Text] [Related]
4. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Nagaya H; Inatomi N; Satoh H
Jpn J Pharmacol; 1991 Apr; 55(4):425-36. PubMed ID: 1886288
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of dimaprit- and pentagastrin-induced gastric acid secretion in cats by the new histamine H2 antagonist, CM 57755.
Lavezzo A; Manzoni L; Bianchetti A; Manara L
J Pharm Pharmacol; 1986 Nov; 38(11):853-6. PubMed ID: 2879021
[TBL] [Abstract][Full Text] [Related]
6. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs.
Takeda M; Takagi T; Maeno H
Eur J Pharmacol; 1983 Aug; 91(4):371-6. PubMed ID: 6137398
[TBL] [Abstract][Full Text] [Related]
8. [Effects of omeprazole and famotidine on (H+-K+) ATPase and acid secretion in rabbit gastric glands].
Tomoi M; Itoh H; Ueda S; Ono T; Shibayama F
Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):105-11. PubMed ID: 2852155
[TBL] [Abstract][Full Text] [Related]
9. Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
Szabó IL; Czimmer J; Szolcsányi J; Mózsik G
Curr Pharm Des; 2013; 19(1):84-9. PubMed ID: 22946903
[TBL] [Abstract][Full Text] [Related]
10. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M
Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685
[TBL] [Abstract][Full Text] [Related]
11. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
[TBL] [Abstract][Full Text] [Related]
12. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K
Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319
[TBL] [Abstract][Full Text] [Related]
13. Selective and competitive histamine H2-receptor blocking effect of famotidine on the blood pressure response in dogs and the acid secretory response in rats.
Miyata K; Kamato T; Fujihara A; Takeda M
Jpn J Pharmacol; 1990 Oct; 54(2):197-204. PubMed ID: 1981794
[TBL] [Abstract][Full Text] [Related]
14. Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression.
Nishida A; Kobayashi-Uchida A; Akuzawa S; Takinami Y; Shishido T; Kamato T; Ito H; Yamano M; Yuki H; Nagakura Y
Am J Physiol; 1995 Nov; 269(5 Pt 1):G699-705. PubMed ID: 7491961
[TBL] [Abstract][Full Text] [Related]
15. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
Kinoshita M; Saito N; Tamaki H
Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
Takeda H; Hokari K; Asaka M
J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616
[TBL] [Abstract][Full Text] [Related]
17. Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs.
De Graef J; Woussen-Colle MC
Gastroenterology; 1986 Aug; 91(2):333-7. PubMed ID: 2873074
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
Okabe S; Shimosako K; Amagase K
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
[TBL] [Abstract][Full Text] [Related]
19. Effects of antisecretory agents on parietal cell structure and H/K-ATPase levels in rabbit gastric mucosa in vivo.
Scott DR; Besancon M; Sachs G; Helander H
Dig Dis Sci; 1994 Oct; 39(10):2118-26. PubMed ID: 7924730
[TBL] [Abstract][Full Text] [Related]
20. Famotidine and ranitidine: any difference in the duration of action?
Coruzzi G; Bertaccini G
Pharmacol Res Commun; 1987 Jan; 19(1):15-27. PubMed ID: 2883670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
